Informing immunotherapy with multi-omics driven machine learning.

Area of Science:

• Oncology
• Computational Biology
• Immunology

Background:

• Immunotherapy has transformed cancer treatment but benefits only specific patient groups.
• Identifying predictive biomarkers is essential for expanding immunotherapy's reach.
• Harnessing multi-omic data is key to understanding complex treatment responses.

Purpose of the Study:

• To review machine learning (ML) models for analyzing omics data in immunotherapy.
• To explore ML applications in predicting immunotherapy response and tumor microenvironment.
• To highlight ML's role in biomarker discovery and understanding treatment mechanisms.

Main Methods:

• Review of current literature on ML applications in cancer immunotherapy.
• Analysis of ML models utilizing diverse omics data (genomics, transcriptomics, etc.).
• Examination of ML techniques for identifying immunotherapy-relevant biomarkers and tumor characteristics.

Main Results:

• ML models effectively leverage multi-omic data for immunotherapy analysis.
• Significant progress in predicting patient response and characterizing the tumor microenvironment.
• Identification of key biomarkers through ML-driven insights.

Conclusions:

• ML is a powerful tool for advancing cancer immunotherapy research.
• Addressing current ML limitations is crucial for future development.
• Optimizing ML strategies will enhance decision-making and treatment efficacy.